[HTML][HTML] Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease …

RJ Black, M Cross, LM Haile, GT Culbreth… - The Lancet …, 2023 - Elsevier
Background Rheumatoid arthritis is a chronic autoimmune inflammatory disease associated
with disability and premature death. Up-to-date estimates of the burden of rheumatoid …

[图书][B] Global status report on road safety 2018

World Health Organization - 2019 - books.google.com
The Global status report on road safety 2018 launched by WHO in December 2018
highlights that the number of annual road traffic deaths has reached 1.35 million. Road traffic …

[HTML][HTML] Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

CJL Murray, AY Aravkin, P Zheng, C Abbafati… - The lancet, 2020 - thelancet.com
Background Rigorous analysis of levels and trends in exposure to leading risk factors and
quantification of their effect on human health are important to identify where public health is …

[HTML][HTML] Organ donation and transplantation: a multi-stakeholder call to action

R Vanholder, B Domínguez-Gil, M Busic… - Nature Reviews …, 2021 - nature.com
Although overall donation and transplantation activity is higher in Europe than on other
continents, differences between European countries in almost every aspect of …

Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment

N Stefan, MB Schulze - The lancet Diabetes & endocrinology, 2023 - thelancet.com
Among 20 leading global risk factors for years of life lost in 2040, reference forecasts point to
three metabolic risks—high blood pressure, high BMI, and high fasting plasma glucose—as …

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial …

WDF Venter, S Sokhela, B Simmons, M Moorhouse… - The lancet HIV, 2020 - thelancet.com
Background ADVANCE compared the efficacy and safety of two antiretroviral first-line
combinations (dolutegravir combined with emtricitabine and either tenofovir disoproxil …

[HTML][HTML] Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

Y He, W Xu, YT Xiao, H Huang, D Gu… - Signal transduction and …, 2022 - nature.com
Prostate cancer (PCa) affects millions of men globally. Due to advances in understanding
genomic landscapes and biological functions, the treatment of PCa continues to improve …

Pooled patient-level analysis of inclisiran trials in patients with familial hypercholesterolemia or atherosclerosis

RS Wright, KK Ray, FJ Raal, DG Kallend… - Journal of the American …, 2021 - jacc.org
Background Inclisiran is a double-stranded small interfering RNA that suppresses proprotein
convertase subtilisin–kexin type 9 (PCSK9) translation in the liver, leading to sustained …

Obesity prevalence in the long-term future in 18 European countries and in the USA

F Janssen, A Bardoutsos, N Vidra - Obesity facts, 2020 - karger.com
Introduction: Obesity constitutes a major public health problem in Europe, but how the
obesity epidemic in European countries will evolve remains unknown. Most previous obesity …

[HTML][HTML] The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic …

A Pourshams, SG Sepanlou, KS Ikuta… - The lancet …, 2019 - thelancet.com
Background Worldwide, both the incidence and death rates of pancreatic cancer are
increasing. Evaluation of pancreatic cancer burden and its global, regional, and national …